INCLINE VILLAGE, Nev.,
Sept. 15, 2011 /PRNewswire/ -- PDL
BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has
paid the September 15, 2011, regular
quarterly dividend payment of $0.15
per share to all stockholders owning shares of PDL as of
September 8, 2011, the record
date.
(Logo:
http://photos.prnewswire.com/prnh/20110822/SF55808LOGO)
About PDL BioPharma
PDL pioneered the humanization of monoclonal antibodies and, by
doing so, enabled the discovery of a new generation of targeted
treatments for cancer and immunologic diseases. Today, PDL is
focused on intellectual property asset management, investing in new
royalty bearing assets and maximizing the value of its patent
portfolio and related assets. For more information, please visit
www.pdl.com.
NOTE: PDL BioPharma and the PDL BioPharma logo are considered
trademarks of PDL BioPharma, Inc.
|
Contacts:
|
|
|
|
Cris Larson
|
Jennifer Williams
|
|
|
PDL BioPharma, Inc.
|
Cook Williams Communications,
Inc.
|
|
|
775-832-8505
|
360-668-3701
|
|
|
cris.larson@pdl.com
|
jennifer@cwcomm.org
|
|
|
|
SOURCE PDL BioPharma, Inc.